WebJun 21, 2000 · Cepheid has raised a total of $117.9M in funding over 7 rounds. Their latest funding was raised on Oct 22, 2024 from a Grant round. Cepheid is registered under the ticker NASDAQ:CPHD . Their stock opened with $6.00 in its Jun 21, 2000 IPO. Cepheid is funded by 5 investors. Webo Cepheid respiratory testing revenue ~$1.2B vs 2024 revenue of ~$3.7B o COVID-19 Vx/Tx revenue of ~$150M vs. 2024 revenue of ~$800M . Operating profit • We …
MSF: COVID-19 test maker Cepheid’s price announcement falls …
WebApr 10, 2024 · Cepheid India Private Limited's operating revenues range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 160.04 % over the previous year. At the same time, it's book networth has increased by 125.54 %. WebMay 7, 2024 · NEW YORK/GENEVA, MAY 7, 2024— US diagnostics corporation Cepheid, which produces the GeneXpert testing machines that run COVID-19 tests—along with tuberculosis (TB), HIV, hepatitis C, and other tests—has announced it will reduce the price of its new 10-color IV-4 GeneXpert machines from $19,000 to $15,800. It also … cdawg va roles
Cepheid - Funding, Financials, Valuation & Investors
Web(dated 25 January 2024),1 Cepheid committed only two million COVID-19 tests over the last six months. In contrast, Cepheid sold nine million COVID-19 cartridges globally in the fourth quarter ... Cepheid surpassed $2 billion in annual revenue in 2024,2 representing 100% growth over the previous year, largely through sales of the SARS-CoV-2 ... WebSep 6, 2016 · Based on its public disclosures, Cepheid generated annual revenues of $539 million in 2015, with double-digit year-on-year organic revenue growth and greater than 75% of these revenues considered recurring. Cepheid has disclosed that in 2016 it expects to generate $618 to $635 million in revenues. WebFunding, Valuation & Revenue. 6 Fundings. Cepheid's latest funding round was a Grant for $28M on July 30, 2024. Cepheid's valuation in November 2016 was $4,000M. … cdawgva last name